Article

Estimates of presumed population immunity to SARS-CoV-2 by state in the United States, August 2021

2021-09-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Information is needed to monitor progress toward a level of population immunity to SARS-CoV-2 sufficient to disrupt viral transmission. We estimated the percentage of the United States (US) population with presumed immunity to SARS-CoV-2 due to vaccination, natural infection, or both as of August 26, 2021. <h4>Methods</h4> Publicly available data as of August 26, 2021, from th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8d9d5ba4-28b9-5f35-9177-0c9bf1587a21
DOI: 10.1101/2021.09.17.21263759

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Estimates of presumed population immunity to SARS-CoV-2 by state in the United States, August 2021DOI 10.1101/2021.09.17.21263759Read

National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysisSemantic proximity Read

Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022Semantic proximity Read

Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021Semantic proximity Read

SARS-CoV-2 attack rate and population immunity in southern New England, March 2020 - May 2021Semantic proximity Read

Risk of SARS-CoV-2 Infection and Hospitalization in Individuals with Natural, Vaccine-Induced and Hybrid Immunity: A Retrospective Nationwide Study from EstoniaSemantic proximity Read

Herd immunity induced by COVID-19 vaccination programs and suppression of epidemics caused by the SARS-CoV-2 Delta variant in ChinaSemantic proximity Read

First “snap-shot” meta-analysis to estimate the prevalence of serum antibodies to SARS-CoV-2 in humansSemantic proximity Read

Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regressionSemantic proximity Read

Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022Semantic proximity Read

U.S. CDC support to international <i>SARS-CoV-2</i> seroprevalence surveys, May 2020–February 2022Semantic proximity Read

Estimating the distribution of COVID-19-susceptible, -recovered, and -vaccinated individuals in Germany up to April 2022Semantic proximity Read

An immune correlate of SARS-CoV-2 infection and severity of reinfectionsSemantic proximity Read